Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEST-Fluids kidney transplant fluid trial
ACTRN12617000358347Phase 3Completed
- Sponsor
- Australasian Kidney Trials Network
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of plasma-lyte and sodium chloride in delayed graft function (DGF), sponsored by Australasian Kidney Trials Network. Started Jan 2018; status: completed.
02
Drugs
plasma-lytesodium chloride
03
Conditions
delayed graft function (DGF)
Beyond the preview
Go deeper on ACTRN12617000358347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000358347.